Audubon, PA-based Globus Medical, Inc. has an extensive portfolio comprising ... Globus Medical registered the highest number of Excelsius unit placements since launch. Zacks Investment Research ...

NuVasive, Inc. NuVasive is a company specializing ... 2023 that it is going to merge with Globus Medical (GMED). Globus also has its own VR solution, with the Exclesius GPS Navigation Robot and the ...

Globus Medical Inc. (NYSE:GMED), a leading medical device company specializing in musculoskeletal disorders, has been making waves in the healthcare sector with its recent acquisition of Nevro Corp ...

StockNews.com upgraded shares of Globus Medical (NYSE:GMED – Free Report) from a hold rating to a buy rating in a research ...

Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...

NYSE:GMED opened at $92.35 on Thursday. The company has a market cap of $12.58 billion, a PE ratio of 137.83, a price-to-earnings-growth ratio of 1.78 and a beta of 1.19. The company has a 50 day ...

The nation’s GPs want the federal government to invest ... with a total funding requirement of more than $3 billion. The medical system is under stress. Getty It will argue the measures will ...

Globus Medical and Nevro Preliminary Full-Year 2024 Revenue Outlook: On January 8, 2025, Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year ...

Globus Medical (NYSE:GMED) said it has agreed to buy Nevro (NVRO) through an all-cash deal with an equity value of around $250M. Under the deal, Globus Medical (NYSE:GMED) will buy all of Nevro's ...

(RTTNews) - Globus Medical (GMED), a musculoskeletal solutions company, Thursday agreed to acquire Nevro Corp. (NVRO), a medical device company, in an all-cash transaction. Under the terms of the ...